AU2001294563A1 - Methods and compositions for glycosidase assays - Google Patents

Methods and compositions for glycosidase assays

Info

Publication number
AU2001294563A1
AU2001294563A1 AU2001294563A AU9456301A AU2001294563A1 AU 2001294563 A1 AU2001294563 A1 AU 2001294563A1 AU 2001294563 A AU2001294563 A AU 2001294563A AU 9456301 A AU9456301 A AU 9456301A AU 2001294563 A1 AU2001294563 A1 AU 2001294563A1
Authority
AU
Australia
Prior art keywords
binding partner
substrate
activity
biotin
heparanase
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001294563A
Other languages
English (en)
Inventor
Sivaram Pillarisetti
Uday Saxena
Dongyan Wang
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Reddy US Therapeutics Inc
Original Assignee
Reddy US Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Reddy US Therapeutics Inc filed Critical Reddy US Therapeutics Inc
Publication of AU2001294563A1 publication Critical patent/AU2001294563A1/en
Assigned to REDDY US THERAPEUTICS, INC reassignment REDDY US THERAPEUTICS, INC Amend patent request/document other than specification (104) Assignors: DONGYAN WANG, REDDY US THERAPEUTICS, INC
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57484—Immunoassay; Biospecific binding assay; Materials therefor for cancer involving compounds serving as markers for tumor, cancer, neoplasia, e.g. cellular determinants, receptors, heat shock/stress proteins, A-protein, oligosaccharides, metabolites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/90—Enzymes; Proenzymes
    • G01N2333/914—Hydrolases (3)
    • G01N2333/924—Hydrolases (3) acting on glycosyl compounds (3.2)

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Oncology (AREA)
  • Hospice & Palliative Care (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Enzymes And Modification Thereof (AREA)
AU2001294563A 2000-09-15 2001-09-14 Methods and compositions for glycosidase assays Abandoned AU2001294563A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US23307500P 2000-09-15 2000-09-15
US60233075 2000-09-15
PCT/US2001/028862 WO2002023197A2 (fr) 2000-09-15 2001-09-14 Procedes et compositions utilises pour des dosages de glycosidase

Publications (1)

Publication Number Publication Date
AU2001294563A1 true AU2001294563A1 (en) 2002-03-26

Family

ID=22875789

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001294563A Abandoned AU2001294563A1 (en) 2000-09-15 2001-09-14 Methods and compositions for glycosidase assays

Country Status (10)

Country Link
US (1) US6656699B2 (fr)
EP (1) EP1356083A2 (fr)
JP (1) JP2004529606A (fr)
AU (1) AU2001294563A1 (fr)
CA (1) CA2426517A1 (fr)
IL (1) IL154904A0 (fr)
MX (1) MXPA03002243A (fr)
NO (1) NO20031177L (fr)
PL (1) PL366012A1 (fr)
WO (1) WO2002023197A2 (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
PL366012A1 (en) * 2000-09-15 2005-01-24 Reddy Us Therapeutics, Inc. Methods and compositions for glycosidase assays
CA2446962A1 (fr) * 2001-05-09 2002-11-14 Insight Biopharmaceuticals Ltd. Methodes et materiels faisant appel a l'heparanase en tant que marqueur diagnostique pour des troubles hemostatiques
WO2003011119A2 (fr) * 2001-07-31 2003-02-13 Reddy Us Therapeutics, Inc. Procedes et compositions pour le diagnostic et le traitement d'etats vasculaires
WO2005040163A1 (fr) 2003-10-28 2005-05-06 Dr. Reddy's Laboratories Ltd Composes heterocycliques bloquant les effets des produits terminaux avances de glycation
WO2009075774A2 (fr) * 2007-12-05 2009-06-18 Massachusetts Institute Of Technology Particules revêtues de glycosaminoglycane et utilisations

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4859581A (en) 1986-03-10 1989-08-22 Board Of Regents, The University Of Texas System Endoglycosidase assay
JPH05509403A (ja) * 1990-05-31 1993-12-22 ボード オブ リージェンツ，ザ ユニバーシティ オブ テキサス システム マウスおよびヒトメラノーマ（黒色腫）中のヘパラナーゼの免疫化学的方法による位置確定
JPH09504422A (ja) * 1993-07-29 1997-05-06 ジ・アップジョン・カンパニー 抗ヘパラナーゼ化合物を同定し、単離するためのヘパラナーゼの使用
TW565614B (en) 1996-07-18 2003-12-11 Univ Australian Detection of mammalian heparanase activity and purification of mammalian heparanase
US6177545B1 (en) 1997-09-02 2001-01-23 Insight Strategy & Marketing Ltd. Heparanase specific molecular probes and their use in research and medical applications
US5968822A (en) 1997-09-02 1999-10-19 Pecker; Iris Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
US6190875B1 (en) 1997-09-02 2001-02-20 Insight Strategy & Marketing Ltd. Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe
IL135823A0 (en) 1997-10-28 2001-05-20 Univ Australian Isolated nucleic acid molecule encoding mammalian endoglucuronidase and uses therefor
GB9802725D0 (en) 1998-02-09 1998-04-08 Ciba Geigy Ag Organic compounds
US6387643B1 (en) 1998-02-24 2002-05-14 Pharmacia And Upjohn Company Human platelet heparanase polypeptides, polynucleotide molecules that encode them, and methods for the identification of compounds that alter heparanase activity
EP1157118A4 (fr) 1999-03-01 2002-07-17 Insight Strategy & Marketing Polynucleotide codant pour un polypeptide ayant une activite d'heparanase et expression de ce polynucleotide dans des cellules genetiquement modifiees
GB9913415D0 (en) 1999-06-10 1999-08-11 Central Manchester Healthcare Heparanase assay
PL366012A1 (en) * 2000-09-15 2005-01-24 Reddy Us Therapeutics, Inc. Methods and compositions for glycosidase assays

Also Published As

Publication number Publication date
NO20031177D0 (no) 2003-03-14
MXPA03002243A (es) 2004-12-03
CA2426517A1 (fr) 2002-03-21
PL366012A1 (en) 2005-01-24
WO2002023197A2 (fr) 2002-03-21
WO2002023197A3 (fr) 2003-07-24
US6656699B2 (en) 2003-12-02
JP2004529606A (ja) 2004-09-30
NO20031177L (no) 2003-05-14
US20020064806A1 (en) 2002-05-30
IL154904A0 (en) 2003-10-31
EP1356083A2 (fr) 2003-10-29

Similar Documents

Publication Publication Date Title
US4859581A (en) Endoglycosidase assay
AU758485B2 (en) Method of screening for potential anti-metastatic and anti-inflammatory agents using mammalian heparanase as a probe
US9029530B2 (en) Detection of oligosaccharides
US8592140B2 (en) Detection of oligosaccharides
US6656699B2 (en) Methods and compositions for glycosidase assays
Enomoto et al. A simple and rapid assay for heparanase activity using homogeneous time-resolved fluorescence
US7615224B2 (en) Multiplex-bead complex for determination of lysosomal storage disorders
JPS62265998A (ja) ヘパラン硫酸エンドグリコシダーゼアッセイ
US6630295B2 (en) High throughput assay for monitoring polycation or polyanion molecular weight, degradation or synthesis
Nardella et al. Radiolabeled heparan sulfate immobilized on microplate as substrate for the detection of heparanase activity
US7625999B2 (en) Method for testing the ability of an agent to inhibit fibroblast growth factor binding with labeled heparan sulfate
EP2079848B1 (fr) Procédé permettant de déterminer une activité d'enzyme endoglycosidase (héparanase)
US7632654B2 (en) Means and methods for detecting endoglycosidase activity
Kowalewski et al. Decoding the consecutive lysosomal degradation of 3-O-sulfate containing heparan sulfate by Arylsulfatase G (ARSG)
EP1499743B1 (fr) Moyens et procedes de detection d'une activite endoglycosidase
Ziouti et al. Solid phase assays in glycoconjugate research: applications to the analysis of proteoglycans, glycosaminoglycans and metalloproteinases